Dr. Theresa M. Medina
Claim this profileUniversity of Colorado Hospital
About Theresa M. Medina
Education:
- Obtained MD from the University of Colorado School of Medicine in 2015.
- Completed Residency in Internal Medicine at the University of Colorado Hospital in 2018.
- Finished Fellowship in Hematology/Oncology at the University of Colorado Hospital in 2021.
Experience:
- Currently serves as a Hematology and Oncology specialist at the University of Colorado Hospital.
Area of expertise
Melanoma
Theresa M. Medina has run 14 trials for Melanoma. Some of their research focus areas include:
Skin Cancer
Theresa M. Medina has run 8 trials for Skin Cancer. Some of their research focus areas include:
Affiliated Hospitals
University Of Colorado Hospital
University Of Colorado Cancer Center
Clinical Trials Theresa M. Medina is currently running
RP1
for Advanced Skin Cancer in Transplant Patients
This trial tests RP1, a modified virus, in organ transplant recipients with advanced skin cancer. RP1 works by killing cancer cells and boosting the immune system to fight the cancer. The HIV-1 accessory protein Vpr has been shown to induce cell cycle arrest and kill tumor cells by apoptosis.
Recruiting
1 award
Phase 1 & 2
10 criteria
TSR-022
for Advanced Cancer
This trial is testing TSR-022, a new medicine that helps the immune system fight cancer by blocking a protein called TIM-3. TIM-3 has gained prominence as a potential candidate for cancer immunotherapy, where it has been shown that blocking TIM-3 with other treatments enhances the body's ability to fight tumors and suppress their growth. It targets patients with tumors, especially those who may not respond to standard treatments. The goal is to see if this medicine can help the immune system better attack cancer cells.
Recruiting
1 award
Phase 1
More about Theresa M. Medina
Clinical Trial Related
6 years of experience running clinical trials · Led 20 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Theresa M. Medina has experience with
- Nivolumab
- Pembrolizumab
- Ipilimumab
- Avelumab
- TSR-022
- Relatlimab
Breakdown of trials Theresa M. Medina has run
Melanoma
Skin Cancer
Cancer
Merkel Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Theresa M. Medina specialize in?
Theresa M. Medina focuses on Melanoma and Skin Cancer. In particular, much of their work with Melanoma has involved Stage IV patients, or patients who are Stage III.
Is Theresa M. Medina currently recruiting for clinical trials?
Yes, Theresa M. Medina is currently recruiting for 3 clinical trials in Aurora Colorado. If you're interested in participating, you should apply.
Are there any treatments that Theresa M. Medina has studied deeply?
Yes, Theresa M. Medina has studied treatments such as Nivolumab, Pembrolizumab, Ipilimumab.
What is the best way to schedule an appointment with Theresa M. Medina?
Apply for one of the trials that Theresa M. Medina is conducting.
What is the office address of Theresa M. Medina?
The office of Theresa M. Medina is located at: University of Colorado Hospital, Aurora, Colorado 80045 United States. This is the address for their practice at the University of Colorado Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.